
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (29): 3652-3657.DOI: 10.12114/j.issn.1007-9572.2022.0335
Special Issue: 骨健康最新文章合辑; 女性健康最新文章合辑
• Article • Previous Articles Next Articles
Received:2022-02-10
Revised:2022-05-15
Published:2022-10-15
Online:2022-06-30
Contact:
Jian RAN
About author:
通讯作者:
冉建
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0335
| 组别 | 例数 | 病程(年) | 年龄(岁) | 绝经年龄(岁) | BMI (kg/m2) |
|---|---|---|---|---|---|
| 对照组 | 30 | — | 56.8±5.1 | 50.5±4.0 | 25.4±1.1 |
| 轻度疼痛组 | 30 | 3.2±0.9 | 57.9±5.2 | 50.5±3.8 | 25.6±1.0 |
| 中度疼痛组 | 30 | 3.7±1.1 | 57.2±4.9 | 50.1±3.7 | 25.8±1.0 |
| 重度疼痛组 | 30 | 3.8±1.2 | 57.9±4.0 | 50.5±3.6 | 26.2±1.0ab |
| F值 | 2.827 | 0.350 | 0.129 | 2.714 | |
| P值 | 0.065 | 0.789 | 0.943 | 0.048 |
Table 1 Comparison of general data in four groups
| 组别 | 例数 | 病程(年) | 年龄(岁) | 绝经年龄(岁) | BMI (kg/m2) |
|---|---|---|---|---|---|
| 对照组 | 30 | — | 56.8±5.1 | 50.5±4.0 | 25.4±1.1 |
| 轻度疼痛组 | 30 | 3.2±0.9 | 57.9±5.2 | 50.5±3.8 | 25.6±1.0 |
| 中度疼痛组 | 30 | 3.7±1.1 | 57.2±4.9 | 50.1±3.7 | 25.8±1.0 |
| 重度疼痛组 | 30 | 3.8±1.2 | 57.9±4.0 | 50.5±3.6 | 26.2±1.0ab |
| F值 | 2.827 | 0.350 | 0.129 | 2.714 | |
| P值 | 0.065 | 0.789 | 0.943 | 0.048 |
| 组别 | 例数 | E2(ng/L) | T(μg/L) | PRL(μg/L) | LH(U/L) | FSH(U/L) | P(μg/L) |
|---|---|---|---|---|---|---|---|
| 对照组 | 30 | 63.99±22.84 | 0.73±0.39 | 16.55±4.08 | 21.49±10.09 | 31.61±13.06 | 1.27±1.06 |
| 轻度疼痛组 | 30 | 63.50±22.66 | 0.65±0.40 | 16.07±5.69 | 23.35±11.18 | 32.21±13.65 | 1.18±1.01 |
| 中度疼痛组 | 30 | 46.49±22.97ab | 0.55±0.39a | 14.89±5.64 | 24.19±11.86 | 34.43±12.95 | 1.09±0.99 |
| 重度疼痛组 | 30 | 39.98±24.05ab | 0.43±0.36ab | 13.75±5.44 | 25.33±12.92 | 37.15±13.47 | 1.09±0.93 |
| F值 | 8.251 | 3.223 | 1.674 | 0.587 | 1.073 | 0.152 | |
| P值 | <0.001 | 0.025 | 0.176 | 0.625 | 0.363 | 0.928 |
Table 2 Comparison of sex hormone levels in four groups
| 组别 | 例数 | E2(ng/L) | T(μg/L) | PRL(μg/L) | LH(U/L) | FSH(U/L) | P(μg/L) |
|---|---|---|---|---|---|---|---|
| 对照组 | 30 | 63.99±22.84 | 0.73±0.39 | 16.55±4.08 | 21.49±10.09 | 31.61±13.06 | 1.27±1.06 |
| 轻度疼痛组 | 30 | 63.50±22.66 | 0.65±0.40 | 16.07±5.69 | 23.35±11.18 | 32.21±13.65 | 1.18±1.01 |
| 中度疼痛组 | 30 | 46.49±22.97ab | 0.55±0.39a | 14.89±5.64 | 24.19±11.86 | 34.43±12.95 | 1.09±0.99 |
| 重度疼痛组 | 30 | 39.98±24.05ab | 0.43±0.36ab | 13.75±5.44 | 25.33±12.92 | 37.15±13.47 | 1.09±0.93 |
| F值 | 8.251 | 3.223 | 1.674 | 0.587 | 1.073 | 0.152 | |
| P值 | <0.001 | 0.025 | 0.176 | 0.625 | 0.363 | 0.928 |
| 组别 | 例数 | IL-1 | IL-6 | IL-10 | TNF-α |
|---|---|---|---|---|---|
| 对照组 | 30 | 6.13(2.33) | 1.97(0.69) | 49.21(45.05) | 6.09(2.99) |
| 轻度疼痛组 | 30 | 10.74(4.07)a | 3.53(1.45)a | 78.00(71.57) | 7.51(3.49) |
| 中度疼痛组 | 30 | 13.22(4.45)a | 5.42(1.74)a | 100.04(67.32)a | 8.24(4.49)a |
| 重度疼痛组 | 30 | 15.56(4.23)a | 7.47(2.21)ab | 120.72(72.37)ab | 11.59(5.15)ab |
| Z值 | 69.93 | 81.97 | 26.10 | 46.74 | |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 3 Comparison of inflammatory cytokines in synovial fluids in four groups
| 组别 | 例数 | IL-1 | IL-6 | IL-10 | TNF-α |
|---|---|---|---|---|---|
| 对照组 | 30 | 6.13(2.33) | 1.97(0.69) | 49.21(45.05) | 6.09(2.99) |
| 轻度疼痛组 | 30 | 10.74(4.07)a | 3.53(1.45)a | 78.00(71.57) | 7.51(3.49) |
| 中度疼痛组 | 30 | 13.22(4.45)a | 5.42(1.74)a | 100.04(67.32)a | 8.24(4.49)a |
| 重度疼痛组 | 30 | 15.56(4.23)a | 7.47(2.21)ab | 120.72(72.37)ab | 11.59(5.15)ab |
| Z值 | 69.93 | 81.97 | 26.10 | 46.74 | |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 |
| 指标 | rs值 | P值 |
|---|---|---|
| E2 | -0.686 | <0.001 |
| T | -0.454 | <0.001 |
| IL-1 | 0.517 | <0.001 |
| IL-6 | 0.665 | <0.001 |
| IL-10 | 0.162 | 0.128 |
| TNF-α | 0.319 | 0.002 |
Table 4 Correlations of E2 and T in the serum and inflammatory cytokines in synovial fluids with VAS score for degenerative knee pain
| 指标 | rs值 | P值 |
|---|---|---|
| E2 | -0.686 | <0.001 |
| T | -0.454 | <0.001 |
| IL-1 | 0.517 | <0.001 |
| IL-6 | 0.665 | <0.001 |
| IL-10 | 0.162 | 0.128 |
| TNF-α | 0.319 | 0.002 |
| [1] |
|
| [2] |
王芷,宋小星,张富军. 雌激素调控去势小鼠疼痛的炎症机制[J]. 上海交通大学学报:医学版,2017,37(7):936-941. DOI:10.3969/j.issn.1674-8115.2017.07.009.
|
| [3] |
万丽,赵晴,陈军,等. 疼痛评估量表应用的中国专家共识(2020版)[J]. 中华疼痛学杂志,2020,16(3):177-187. DOI:10.3760/cma.j.cn101379-20190915-00075.
|
| [4] |
|
| [5] |
牟利民,张文豪,陈万吉,等. 雌激素及雌激素受体与骨关节炎的相关性研究进展[J]. 浙江医学,2021,43(24):2721-2724. DOI:10.12056/j.issn.1006-2785.2021.43.24.2021-1936.
|
| [6] |
|
| [7] |
|
| [8] |
黄萍,王怡,陈博,等. 膝骨关节炎患者的三维运动解析[J]. 中国全科医学,2020,23(17):2169-2176. DOI:10.12114/j.issn.1007-9572.2019.00.65.
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
孔颖,王国栋,孟纯阳. 膝关节骨性关节炎血清炎性因子与血管生成因子的关系[J]. 中国矫形外科杂志,2019,27(10):916-920. DOI:10.3977/j.issn.1005-8478.2019.10.11.
|
| [23] |
|
| [24] |
黄媛霞,徐海斌,郭春. IL-1β和MMP-13在兔骨关节炎模型软骨和滑液中的表达[J]. 西安交通大学学报:医学版,2017,38(4):507-511,528. DOI:10.7652/jdyxb201704008.
|
| [25] |
桂珍,张淑平,陈小洁. IL-6抑制剂在全身型幼年特发性关节炎治疗中的应用进展[J]. 现代免疫学,2020,40(2):174-177.
|
| [26] |
马玲,贾子善,肖红雨,等. 膝骨性关节炎关节腔内药物注射治疗疗效评价[J]. 中国全科医学,2016,19(9):1067-1070. DOI:10.3969/j.issn.1007-9572.2016.09.017.
|
| [1] | SHI Xiaotian, WANG Shan, YANG Huayu, YANG Yifan, LI Xu, DOU Guoze, MA Qing. A Predictive Nomogram for the Risk of Frailty/Pre-frailty on Inflammatory Biomarkers in the Elderly [J]. Chinese General Practice, 2025, 28(05): 587-593. |
| [2] | ZHANG Gaoyu, WANG Zihan, GAO Xuefei, ZHANG Jin, DAI Tiangu, HE Qing, FAN Jiarong, HUANG Li, LI Lin. Research on the Development of a Risk Model for Coronary Heart Disease in Postmenopausal Hypertensive Women Based on the Triglyceride Glucose Index Combined with Vascular Elasticity Indicators [J]. Chinese General Practice, 2025, 28(01): 39-46. |
| [3] | LU Ran, WU Chunyan, XU Haina, AN Miaomiao, WU Baoqin, LAI Jun, RAN Limei. A Threshold Study of Carotid Plaque Risk in Postmenopausal Middle-aged Women with Normal Homocysteine [J]. Chinese General Practice, 2024, 27(11): 1320-1325. |
| [4] | LIU Yu, YUE Ting, YANG Dongyu, ZHAO Zhongting, YANG Jibo, ZHU Tiantian. Research Progress on Mechanism of Autophagy in the Pathogenesis of Rheumatoid Arthritis [J]. Chinese General Practice, 2023, 26(29): 3710-3714. |
| [5] | LIU Shuangxue, LI Yanhua, ZHANG Gangwei, ZHAO Lin. Risk Factors for Postmenopausal Hypertension: a Meta-analysis [J]. Chinese General Practice, 2023, 26(04): 512-518. |
| [6] | LI Jinyi, LIANG Guicheng, WANG Shirong, LI Shuhu, KE Honghong. Correlation of Markers of Inflammation and Endothelial Injury with Thrombosis in Left Atrium in Patients with Atria Fibrillation [J]. Chinese General Practice, 2022, 25(32): 4018-4022. |
| [7] | Panping LU, Yumei LIAO, Zhelin ZHANG. Value of 3D Ultrasonography with Malignancy Risk Model for Screening for Endometrial Cancer with Postmenopausal Bleeding [J]. Chinese General Practice, 2022, 25(14): 1724-1729,1740. |
| [8] | JIAZIREYA·Zaiyinati,XING Shuqing,RENAGULI·Aikebaier,ZHANG Kaidi,ZHANG Yuyuan,XING Bei,WANG Xinling,GUO Yanying. Prevalence and Characteristics of Thyroid Diseases in Peri- and Post-menopausal Women [J]. Chinese General Practice, 2021, 24(3): 310-315. |
| [9] | CAI Linkun,HUANG Shi,PENG Zhuoyu,HUANG Yalan,TAO Lifen,LAN Siying. Clinical Response and Changes in Intestinal Barrier Function,Inflammatory Markers and Neuropeptide Y among Diarrhea-predominant Irritable Bowel Syndrome with Liver-qi Stagnation and Spleen Deficiency Syndrome Patients Treated with Anchang Decoction [J]. Chinese General Practice, 2020, 23(9): 1169-1174. |
| [10] | CAI Hong,ZHANG Zhifen,TONG Jinyi,CHEN Yun,ZHUO Guangchao,CHEN Yueming,LAI Lei,GE Cenhong. Serum Retinol-binding Protein 4 and Non-alcoholic Fatty Liver Disease in Postmenopausal Women [J]. Chinese General Practice, 2019, 22(4): 433-437. |
| [11] | WANG Yong,CHEN Chunmei,MA Yaping,HANG Biao,HANG Yin,RUI Fang,YAO Min,QIN Liqin,BEN Ze,NIE Shuang,XU Zhuangjian. Relationship of Nutritional Status with Urine Gonadotropin and Sex Hormones in Preschool Boys [J]. Chinese General Practice, 2019, 22(20): 2416-2421. |
| [12] | CHEN Yuning,WEI Peng,SHI Bimin,QIAN Ke,DING Yi. Effects of H-type Hypertension on Bone Metabolism Markers and Inflammatory Factors in Postmenopausal Women with Osteoporosis [J]. Chinese General Practice, 2018, 21(32): 3951-3955. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||